세계의 유전자 회로 치료제 시장 보고서(2025년)

Gene circuit therapeutics refers to medical treatments that employ engineered gene networks within cells to regulate their behavior. These gene circuits function as miniature biological programs, activating or deactivating genes in response to specific signals. Such therapeutics enable more precise disease management by allowing immune cells to target cancer or by safely controlling other cellular functions.

The primary product categories in gene circuit therapeutics include synthetic gene circuits, programmable cell therapies, gene editing tools, and related products. Synthetic gene circuits consist of engineered networks of artificial genetic elements that interact to regulate gene expression, influence cellular behavior, and control the production or modification of DNA and RNA for targeted therapies. Progress in this field is driving the creation of highly precise treatments for complex medical conditions. Core technologies include CRISPR, TALEN, zinc finger nucleases, and similar tools. Applications span oncology, rare diseases, infectious diseases, regenerative medicine, and more, and are employed by pharmaceutical and biotech companies, research and academic institutions, hospitals, and clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The gene circuit therapeutics market research report is one of a series of new reports from The Business Research Company that provides gene circuit therapeutics market statistics, including gene circuit therapeutics industry global market size, regional shares, competitors with the gene circuit therapeutics market share, gene circuit therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the gene circuit therapeutics industry. This gene circuit therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene circuit therapeutics market size has grown exponentially in recent years. It will grow from $1.50 billion in 2024 to $1.84 billion in 2025 at a compound annual growth rate (CAGR) of 22.5%. The growth during the historic period is driven by the expanding study of quorum sensing-based gene circuits, increased use of epigenetic regulatory modules, development of bio-computational therapeutic frameworks, incorporation of optogenetic control systems, and rising interest in non-coding RNA-mediated circuit designs.

The gene circuit therapeutics market size is expected to see exponential growth in the next few years. It will grow to $4.12 billion in 2029 at a compound annual growth rate (CAGR) of 22.3%. The projected growth in the forecast period is supported by broader adoption of cell-based therapies, growing investment in synthetic biology research, rising demand for personalized medicine, increased government funding for gene therapy development, and advancements in gene editing technologies. Key trends in this period include progress in programmable gene network therapies, refined cell-specific gene circuit modulation, innovations in synthetic feedback loop design, integration of computational modeling for circuit optimization, and development of controllable therapeutic gene switches.

The rising demand for personalized medicine is set to drive the expansion of the gene circuit therapeutics market. Personalized medicine involves customizing treatment based on the individual genetic, biomarker, or molecular profile of each patient. The increased demand for personalized approaches is largely fueled by advancements in genomics and synthetic biology, which enable more accurate targeting of diseases and better therapeutic outcomes. Gene circuit therapeutics play a key role by engineering cells and microorganisms with programmable logic that allows them to sense, compute, and respond to specific disease conditions, leading to more effective and individualized treatments. For example, NHS England reported that the total number of personalized genomic tests reached 65,884 in 2024, reflecting a 14% increase from 2023, which underscores the growing demand for personalized medicine. As a result, this demand is driving the growth of the gene circuit therapeutics market.

Key players in the gene circuit therapeutics market are focusing on developing programmable gene circuits that enable more precise disease targeting, controlled therapeutic responses, and enhanced treatment safety. These programmable circuits are genetic networks designed from DNA, RNA, and regulatory proteins, which mimic logical operations in cells to detect biological signals, process them, and produce specific outputs. For instance, in May 2023, Synlogic, Inc., a US-based biotechnology company, presented new data at the Synthetic Biology Engineering, Evolution & Design (SEED) Conference on SYNB1353, a Synthetic Biotic drug candidate for homocystinuria (HCU). This drug uses genetically engineered probiotic bacteria with metabolic gene circuits to consume methionine and reduce toxic homocysteine levels. This application of programmable circuits shows their potential not only in oncology but also in treating rare metabolic disorders, highlighting their ability to create targeted, durable, and patient-friendly treatments.

In June 2022, Senti Biosciences Inc., a US-based company specializing in next-generation cell and gene therapies using gene circuits, merged with Dynamics Special Purpose Corp. in a $156.5 million business deal. The merger was aimed at strengthening Senti's capital position, advancing its proprietary gene circuit platform, and accelerating the development of its off-the-shelf CAR-NK cell therapies targeting cancer. Dynamics Special Purpose Corp. was a US-based special purpose acquisition company focused on healthcare and life sciences platforms, including synthetic biology and innovative drug discovery technologies.

Major players in the gene circuit therapeutics market are GenScript Biotech, Agilent Technologies, Cellectis S.A., CRISPR Therapeutics, Beam Therapeutics, Twist Bioscience, Ginkgo Bioworks, Sangamo Therapeutics, Senti Biosciences, Editas Medicine, BlueRock Therapeutics, Synthego Corporation, Manus Bio, Strand Therapeutics, Dyno Therapeutics, Obsidian Therapeutics, Rubius Therapeutics, Precigen Inc., Aurealis Therapeutics, Synlogic Inc., Azalea Therapeutics.

North America was the largest region in the gene circuit therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gene circuit therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gene circuit therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene circuit therapeutics market consists of revenues earned by entities by providing services such as cellular pathway modeling, gene circuit testing and validation, therapeutic gene delivery consulting, immune cell engineering support, and bioinformatics analysis for circuit optimization. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene circuit therapeutics market includes sales of gene delivery vectors, inducible gene switches, synthetic promoters, engineered regulatory proteins, and cell-based assay kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Circuit Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene circuit therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene circuit therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gene circuit therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Synthetic Gene Circuits; Programmable Cell Therapies; Gene Editing Tools; Other Product Types
• 2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR); Transcription Activator-Like Effector Nuclease (TALEN); Zinc Finger Nucleases; Other Technologies
• 3) By Application: Oncology; Rare Diseases; Infectious Diseases; Regenerative Medicine; Other Applications
• 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Hospitals And Clinics; Other End-Users
• Subsegments:
• 1) Synthetic Gene Circuits: Switch-based Circuits; Logic Gate Circuits; Oscillatory Circuits; Memory Circuits
• 2) Programmable Cell Therapies: CAR-T Cell Therapy; TCR-T Cell Therapy; NK Cell Therapy; Stem Cell-Based Therapies
• 3) Gene Editing Tools: CRISPR-Cas Systems; TALENs; Zinc Finger Nucleases (ZFNs); Meganucleases
• 4) Others: RNA-Based Therapeutics; Antisense Oligonucleotides; Epigenome Editing Tools
• Companies Mentioned: GenScript Biotech; Agilent Technologies; Cellectis S.A.; CRISPR Therapeutics; Beam Therapeutics; Twist Bioscience; Ginkgo Bioworks; Sangamo Therapeutics; Senti Biosciences; Editas Medicine; BlueRock Therapeutics; Synthego Corporation; Manus Bio; Strand Therapeutics; Dyno Therapeutics; Obsidian Therapeutics; Rubius Therapeutics; Precigen Inc.; Aurealis Therapeutics; Synlogic Inc.; Azalea Therapeutics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene Circuit Therapeutics Market Characteristics

3. Gene Circuit Therapeutics Market Trends And Strategies

4. Gene Circuit Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gene Circuit Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gene Circuit Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gene Circuit Therapeutics Market Growth Rate Analysis
• 5.4. Global Gene Circuit Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gene Circuit Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gene Circuit Therapeutics Total Addressable Market (TAM)

6. Gene Circuit Therapeutics Market Segmentation

• 6.1. Global Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Gene Circuits
• Programmable Cell Therapies
• Gene Editing Tools
• Other Product Types
• 6.2. Global Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
• Transcription Activator-Like Effector Nuclease (TALEN)
• Zinc Finger Nucleases
• Other Technologies
• 6.3. Global Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Rare Diseases
• Infectious Diseases
• Regenerative Medicine
• Other Applications
• 6.4. Global Gene Circuit Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Academic And Research Institutes
• Hospitals And Clinics
• Other End-Users
• 6.5. Global Gene Circuit Therapeutics Market, Sub-Segmentation Of Synthetic Gene Circuits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Switch-based Circuits
• Logic Gate Circuits
• Oscillatory Circuits
• Memory Circuits
• 6.6. Global Gene Circuit Therapeutics Market, Sub-Segmentation Of Programmable Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CAR-T Cell Therapy
• TCR-T Cell Therapy
• NK Cell Therapy
• Stem Cell-Based Therapies
• 6.7. Global Gene Circuit Therapeutics Market, Sub-Segmentation Of Gene Editing Tools, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR-Cas Systems
• TALENs
• Zinc Finger Nucleases (ZFNs)
• Meganucleases
• 6.8. Global Gene Circuit Therapeutics Market, Sub-Segmentation Of Others, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• RNA-Based Therapeutics
• Antisense Oligonucleotides
• Epigenome Editing Tools

7. Gene Circuit Therapeutics Market Regional And Country Analysis

• 7.1. Global Gene Circuit Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gene Circuit Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Circuit Therapeutics Market

• 8.1. Asia-Pacific Gene Circuit Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Circuit Therapeutics Market

• 9.1. China Gene Circuit Therapeutics Market Overview
• 9.2. China Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Circuit Therapeutics Market

• 10.1. India Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Circuit Therapeutics Market

• 11.1. Japan Gene Circuit Therapeutics Market Overview
• 11.2. Japan Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Circuit Therapeutics Market

• 12.1. Australia Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Circuit Therapeutics Market

• 13.1. Indonesia Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Circuit Therapeutics Market

• 14.1. South Korea Gene Circuit Therapeutics Market Overview
• 14.2. South Korea Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Circuit Therapeutics Market

• 15.1. Western Europe Gene Circuit Therapeutics Market Overview
• 15.2. Western Europe Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Circuit Therapeutics Market

• 16.1. UK Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Circuit Therapeutics Market

• 17.1. Germany Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Circuit Therapeutics Market

• 18.1. France Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Circuit Therapeutics Market

• 19.1. Italy Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Circuit Therapeutics Market

• 20.1. Spain Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Circuit Therapeutics Market

• 21.1. Eastern Europe Gene Circuit Therapeutics Market Overview
• 21.2. Eastern Europe Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Circuit Therapeutics Market

• 22.1. Russia Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Circuit Therapeutics Market

• 23.1. North America Gene Circuit Therapeutics Market Overview
• 23.2. North America Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Circuit Therapeutics Market

• 24.1. USA Gene Circuit Therapeutics Market Overview
• 24.2. USA Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Circuit Therapeutics Market

• 25.1. Canada Gene Circuit Therapeutics Market Overview
• 25.2. Canada Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Circuit Therapeutics Market

• 26.1. South America Gene Circuit Therapeutics Market Overview
• 26.2. South America Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Circuit Therapeutics Market

• 27.1. Brazil Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Circuit Therapeutics Market

• 28.1. Middle East Gene Circuit Therapeutics Market Overview
• 28.2. Middle East Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Circuit Therapeutics Market

• 29.1. Africa Gene Circuit Therapeutics Market Overview
• 29.2. Africa Gene Circuit Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gene Circuit Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gene Circuit Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Circuit Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Gene Circuit Therapeutics Market Competitive Landscape
• 30.2. Gene Circuit Therapeutics Market Company Profiles
  • 30.2.1. GenScript Biotech Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Agilent Technologies Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Cellectis S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. CRISPR Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Beam Therapeutics Overview, Products and Services, Strategy and Financial Analysis

31. Gene Circuit Therapeutics Market Other Major And Innovative Companies

• 31.1. Twist Bioscience
• 31.2. Ginkgo Bioworks
• 31.3. Sangamo Therapeutics
• 31.4. Senti Biosciences
• 31.5. Editas Medicine
• 31.6. BlueRock Therapeutics
• 31.7. Synthego Corporation
• 31.8. Manus Bio
• 31.9. Strand Therapeutics
• 31.10. Dyno Therapeutics
• 31.11. Obsidian Therapeutics
• 31.12. Rubius Therapeutics
• 31.13. Precigen Inc.
• 31.14. Aurealis Therapeutics
• 31.15. Synlogic Inc.

32. Global Gene Circuit Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Circuit Therapeutics Market

34. Recent Developments In The Gene Circuit Therapeutics Market

35. Gene Circuit Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Gene Circuit Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gene Circuit Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gene Circuit Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer